A vasopressin-sensitive mechanism within the medial preoptic area-anterior hypothalamus (MPOA-AH) appears to be essential for expression of a complex behavior involved in olfactory communication in Golden hamsters called flank marking. The present study investigated whether the induction of flank marking by arginine-vasopressin (AVP) within the MPOA-AH is mediated by a receptor that is more similar to the vasopressor (Vl) or the antidiurectic (V2) AVP receptor. Adult male hamsters were anesthetized and implanted with a 26 gauge guide cannula stereotaxically aimed at the MPOA-AH and then microinjected with analogs of vasopressin, oxytocin, and selective Vl and V2 antagonists. Hamsters were tested for flank-marking behavior during a 5 or 10 min observation period following the injection of peptlde in a vehicle of 100 nl of saline. None of the 15 analogs of AVP and oxytocin produced more flank marking than the 50.8 + 16.2 and 76.8 f 4.4 (mean f SEW, II = 4) flank marks observed following injection of AVP at the 1 or 10 ng dose, respectively. The number of flank marks produced by each analog was found to be highly related to the pressor activity of that analog at both the 1 ng (p = +0.74, p < 0.01) and 10 ng (p = +0.82, p < 0.01) doses. In contrast, no statistically reliable relationship between flank marking and the antidiuretic activity of these analogs was found at either dose (1 ng: p = +O.O7,p > 0.05; 10 ng: p = +O.lO,p > 0.05). In a second series of studies, microinjection of 2 different Vl antagonists into the MPOA-AH significantly (p < 0.005) inhibited flank marking in response to AVP. However, microinjection of a V2 antagonist or saline did not inhibit flank marking. These data indicate that the receptors mediating the induction of 'flank marking within the MPOA-AH are more similiar to Vl (pressor) receptors than to V2 (antidiuretic) receptors.
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Scent marking is a major form of communication in mammals.
Odors deposited in the environment can serve a variety of social functions from attracting mates to repelling competitors (Yahr, 1984) . In the Golden hamster (Mesocricetus auratus), one form of scent marking, termed flank gland marking, is accomplished by rubbing a dorsal flank gland against vertical objects in the environment. Flank gland marking is commonly observed in both male and female hamsters and can be elicited by the odors of other hamsters and aggression during social encounters (Johnston, 1975) .
Several lines of evidence now indicate that neurons within the medial preoptic area-anterior hypothalamus (MPOA-AH) are critical for the expression of scent marking behavior. Lesions that destroy the MPOA-AH severely reduce scent-marking behavior in several mammalian species (Hart, 1974; Hart and Voith, 1978; Yahr, 1984) . Implants of testosterone into the MPOA-AH can override deficits in scent marking produced by castration (Thiessen and Yahr, 1970; Thiessen et al., 1973) .
One of the neurochemicals involved in the control of flankmarking behavior within the MPOA-AH has been identified recently. Injection of arginine-vasopressin (AVP), but not other peptides or putative neurotransmitters, into the MPOA-AH triggers intense bouts of flank-marking behavior in hamsters Ferris et al., 1984 ). An AVP antagonist injected into the MPOA-AH not only inhibits flank marking in response to AVP, but also flank marking stimulated by the odors of other hamsters . These data indicate that an AVP-sensitive mechanism within the MPOA-AH is essential for the expression of flank-marking behavior.
The receptors that mediate the response to AVP within the MPOA-AH have not been identified. The well-known vasopressor and antidiurectic activities of AVP appear to be mediated by 2 separate classes of receptors, V 1 and V2, respectively (Michell et al., 1979) . To determine whether the control offlankmarking behavior by AVP within the MPOA-AH is mediated by a Vl-or a V2-like receptor, the effects of selective Vl and V2 agonists and antagonists on this behavior were determined after injections into the MPOA-AH.
Materials and Methods
Adult male hamsters (M. aurutus) purchased from Engle Laboratory Animals (Farmersbury, IN) were housed in a 14: 10 light-dark cycle and provided free access to food and water. All hamsters were anesthetized with sodium pentobarbital and implanted with a 26 gauge guide cannula stereotaxically aimed at the MPOA-AH. Stereotaxic coordinates were 1.2 mm anterior to bregma, 1.7 mm lateral, and 8 mm ventral from dura with an 8" angle from lateral to medial. All hamsters were allowed to recover from surgery for at least 2 d before experiments were run.
All behavioral testing was done in a clean 24 x 32 x 20 cm Plexiglas cage. A flank mark was scored each time a hamster rubbed its dorsal flank gland against the cage wall or comer in association with forward movement. The total number of flank marks was recorded for either 5 or 10 min test periods (see Results) immediately following peptide injection. Microinjections did not require anesthesia and were made with a 33 gauge needle attached to a microliter Hamilton syringe. All peptides were coded arbitrarily, so the substance tested was unknown to the observer. The Kimbrough et al., 1963 Botos et al., 1979 Berde et al., 1964 Gillessen and du Vigneaud, 1970 Gillessen and du Vigneaud, 1970 Chan and du Vigneaud, 1962 Smith et al., 1980 Fenier et al., 1965 Walter et al., 1976 Sawyer et al., 1974 Botos et al., 1979 Manning et al., 1984 Bankowski et al., 1978 Kruszynski et al., 1980 late Dr. Roderich Walter and the late Dr. Vincent du Vigneaud, Cornell the Spearman's rank-difference correlation method (Guilford, 1956 ). Universitv. The uressor and antidiuretic activities of these peptides can be found in Table 1 .
Statistical analysis of selective AVP antagonists was determined by oneway analysis of variance and Dunnett's test of paired comparisons. Following the experiment, hamsters were anesthetized with sodium nentobarbital and nerfused intracardiallv with Perlix (Fisher Scientific). Brains were removed, cut on a freezing microtome,'and then stained with cresyl violet. Injection sites were then evaluated under light microscopy.
All correlations and their statistical significance were determined with DOSE-RESPONSE CURVE 
Results

Doseresponse relationship
To determine whether AVP induced flank marking in a dosedependent manner, the compound was injected (in 100 nl of saline) into the MPOA-AH in doses ranging from 0.1 to 1000 ng. To standardize the comparison of AVP across doses, all hamsters were initially screened with 1 ng of AVP into the MPOA-AH. Only those hamsters exhibiting between 20 and 40 flank marks during this initial test were subsequently tested at 1 or 2 other doses of AVP. As can be seen in Figure 1 , the number of flank marks observed after AVP injection increased at doses ranging from 0.1 to 10 ng. The dose of AVP that caused half-maximal stimulation of flank marking (i.e., 30 flank marks in the 5 min test) was 1.0 ng (ca. 5 PM). The number of flank marks leveled off at approximately 40 after doses of AVP above 10 ng.
Induction offlank marking by vasopressin and oxytocin analogs
The number of flank marks observed following injection of vasopressin and oxytocin analogs was determined during a 10 min test at doses of both 1 and 10 ng (Table 2) . No analog was found to be more potent than AVP in the induction of flankmarking behavior; however, both (8-lysine) vasopressin and (2-phenylalanine Sornithine) vasotocin produced about the same number of flank marks as AVP at both the 1 and 10 ng. Analogs that produced more than 10 flank marks at the 1 ng dose resulted in more flank marking at the 10 ng dose. This dose-response relationship was not observed for analogs that produced fewer than 10 flank marks. Injection of vasopressin metabolite neuropeptide, i.e., AVP(4-9), which has been reported to be highly active in facilitating memory consolidation (Burbach et al., 1983) did not produce flank marking (Table 2) . Since the pressor and antidiuretic activities of these analogs have been reported previously (Table l) , it was possible to compare the pressor and antidiuretic activity of each analog with its ability to induce flank marking. The amount of flank marking produced by each peptide was highly related to its activity in the rat blood pressure bioassay (Fig. 2) . At both doses a statistically significant positive correlation was found between pressor activity and flank marking (1 ng: p = +0.74, p < 0.01; 10 ng: p = +0.82, p < 0.01). In contrast, no statistically significant relationship was observed between antidiuretic activity and flank marking at either the 1 ng b = +0.07, p > 0.05) or the 10 ng dose Co = +O.lO, p > 0.05).
Inhibition ofjlank marking by selective A VP antagonists
The properties of the receptors mediating flank-marking behavior within the MPOA-AH were examined further with 2 selective antagonists of pressor activity-i.e., [ 1 -deaminopeni- As we have described previously , the Vl antagonist dPTry(Me)AVP initially has agonistic activity followed by antagonistic activity. As a result, the ability of AVP to induce flank marking was tested 90 min after injection of dPTry(Me)AVP (n = 5). As can be seen in Figure 3 , dPTry(Me)AVP, like Manning Compound, produced a significant (p < 0.005) inhibition of flank marking in response to AVP injected into the MPOA-AH. Discussion AVP induces flank marking in a dose-dependent fashion when injected into the MPOA-AH. The concentration that produces half-maximal stimulation of flank-marking behavior is 1 ng (in 100 nl saline) or approximately 5 PM. In several studies that examined AVP binding in rat brain, Scatchard analysis showed the existence of high-and low-affinity binding sites with dissociation equilibrium constants (Kd) of approximately 1 and 20 nM, respectively (Brinton et al., 1984; Lawrence et al., 1984; Pearlmutter et al., 1983) . Without taking into consideration the diffusion and degradation of AVP that may occur following its injection into the brain, the concentration of peptide employed in these studies is only about 200-fold greater than these Kd.
The degree to which flank-marking behavior was induced by vasopressin and oxytocin analogs within the MPOA-AH was highly correlated with the pressor, but not the antidiuretic, activity of these peptides. Similarly, pressor antagonists, but not antidiuretic antagonists, injected into the MPOA-AH inhibited flank marking in response to AVP. These data indicate that the receptor that mediates flank-marking behavior in the MPOA-AH of the hamster is more similar to the Vl pressor receptor than to the V2 antidiuretic receptor.
Other studies have investigated the receptor mediating vasopressin activity within the CNS and pituitary. In mice, vasopressin injected into the cerebroventricles produces a variety of behavioral changes, such as excessive grooming and scratching (Meisenberg and Simmons, 1982) . These behavioral effects were found to be positively correlated with the pressor activity, but not the antidiuretic activity, of vasopressin and oxytocin analogs. Studies of vasopressin activity in the pituitary also suggest that a Vl-like receptor is involved in adrenocorticotropic hormone (ACTH) release by vasopressin (Aizawa et al., 1982) . A selective Vl antagonist, but not a V2 antagonist, was found to inhibit vasopressin-stimulated ACTH release (Rivier et al., 1984) . More recently, studies examining the binding of vasopressin to isolated pituitary cells and AVP-induced ACTH release from these cells suggested that a subtype of Vl receptor may be involved in mediating vasopressin activity in the pituitary (Gaillard et al., 1985) .
The effects of AVP on learning and memory appear to be mediated by mechanisms very different from those of AVP on other behaviors and pituitary secretion. It has been hypothesized that AVP(4-9) is a metabolic product of AVP in brain and that this AVP fragment mediates the learning and memory effects previously attributed to AVP (Burbach et al., 1983) . In support of this view, AVP(4-9) has been found to be a thousand times more potent than AVP in facilitating consolidation of passiveavoidance behavior. In the present study, AVP(4-9) was ineffective in inducing flank-marking behavior when injected into the MPOA-AH, which is not surprising since it has little or no pressor activity (Burbach et al., 1983) . It would therefore seem that the receptor that mediates flank-marking behavior is quite different from the receptor that mediates the memory and learning effects of AVP.
